BGIM
AMGN icon

Boussard & Gavaudan Investment Management’s Amgen AMGN Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,888
Closed -$541K – 91
2023
Q4 		$541K Buy
+1,888
New +$514K 0.11% 52

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Boussard & Gavaudan Investment Management's AMGN Position: Q1 2024 in Review

Boussard & Gavaudan Investment Management sold out of Amgen (AMGN) in Q1 2024, closing a stake of 1,888 shares — an estimated $541K sold.

Boussard & Gavaudan Investment Management first reported a position in AMGN in Q4 2023 and held it in 1 quarter. The position peaked at $541K in Q4 2023. 2,716 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Boussard & Gavaudan Investment Management reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
  • Boussard & Gavaudan Investment Management sold 1,888 Amgen shares in Q1 2024, an estimated $541K.
  • Boussard & Gavaudan Investment Management first reported a position in Amgen in Q4 2023 and held it in 1 quarter.
  • Boussard & Gavaudan Investment Management's Amgen position peaked at $541K in Q4 2023.
  • 2,716 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q1 2024, filed 14 May 2024.